Mackenzie Financial Corp Purchases 96,506 Shares of Waters Corporation $WAT

Mackenzie Financial Corp grew its holdings in shares of Waters Corporation (NYSE:WAT) by 87.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 206,670 shares of the medical instruments supplier’s stock after acquiring an additional 96,506 shares during the period. Mackenzie Financial Corp owned 0.35% of Waters worth $72,136,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in WAT. Zions Bancorporation National Association UT acquired a new stake in Waters during the first quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Waters during the 1st quarter worth approximately $41,000. IFP Advisors Inc grew its position in shares of Waters by 65.4% during the 2nd quarter. IFP Advisors Inc now owns 134 shares of the medical instruments supplier’s stock worth $51,000 after buying an additional 53 shares during the period. Creative Financial Designs Inc. ADV increased its stake in shares of Waters by 533.3% in the 2nd quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock valued at $66,000 after acquiring an additional 160 shares in the last quarter. Finally, Steph & Co. acquired a new position in shares of Waters during the 2nd quarter valued at $73,000. 94.01% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. TD Cowen raised their price target on shares of Waters from $345.00 to $390.00 and gave the stock a “hold” rating in a report on Wednesday, November 5th. Redburn Partners set a $390.00 target price on Waters in a research note on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waters in a research note on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft set a $315.00 price target on Waters and gave the stock a “hold” rating in a report on Tuesday, August 5th. Finally, Cowen restated a “hold” rating on shares of Waters in a report on Wednesday, November 5th. Two analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $381.57.

Waters Price Performance

WAT stock opened at $403.42 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. The business has a 50-day simple moving average of $350.26 and a two-hundred day simple moving average of $330.69. The company has a market capitalization of $24.02 billion, a P/E ratio of 36.38, a price-to-earnings-growth ratio of 3.19 and a beta of 1.11. Waters Corporation has a 52-week low of $275.05 and a 52-week high of $423.56.

Waters (NYSE:WAT) last posted its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. The company had revenue of $608.55 million for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%. Research analysts expect that Waters Corporation will post 12.86 EPS for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.